Y Möroi

2.0k total citations · 2 hit papers
19 papers, 1.6k citations indexed

About

Y Möroi is a scholar working on Pathology and Forensic Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Y Möroi has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Y Möroi's work include Systemic Sclerosis and Related Diseases (8 papers), Inflammatory Myopathies and Dermatomyositis (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Y Möroi is often cited by papers focused on Systemic Sclerosis and Related Diseases (8 papers), Inflammatory Myopathies and Dermatomyositis (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Y Möroi collaborates with scholars based in Japan, United States and Czechia. Y Möroi's co-authors include Eng M. Tan, Carol Peebles, Marvin J. Fritzler, James C. Steigerwald, Gerald P. Rodnan, Ignacio Garcı́a-De La Torre, Kazuhiko Takehara, Paul K. Nakane, Yasumasa Ishibashi and Tomofumi Miyamoto and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

In The Last Decade

Y Möroi

18 papers receiving 1.4k citations

Hit Papers

Autoantibody to centromere (kinetochore) in scleroderma s... 1980 2026 1995 2010 1980 1980 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Möroi Japan 11 682 517 493 355 287 19 1.6k
H Griesser Canada 17 899 1.3× 416 0.8× 61 0.1× 111 0.3× 535 1.9× 33 1.6k
Robert Coupland Canada 22 844 1.2× 429 0.8× 56 0.1× 73 0.2× 241 0.8× 40 1.7k
Rosangela Donghi Italy 15 358 0.5× 909 1.8× 234 0.5× 35 0.1× 62 0.2× 23 2.0k
Basile Tessier‐Cloutier Canada 23 359 0.5× 555 1.1× 328 0.7× 104 0.3× 145 0.5× 70 1.6k
W. F. Benedict United States 9 242 0.4× 998 1.9× 89 0.2× 25 0.1× 107 0.4× 11 1.9k
Preben Philip Denmark 25 404 0.6× 978 1.9× 99 0.2× 68 0.2× 189 0.7× 69 2.8k
Susumu Matsukuma Japan 18 277 0.4× 352 0.7× 107 0.2× 88 0.2× 32 0.1× 101 1.6k
Bruce G. Kulander United States 12 207 0.3× 220 0.4× 87 0.2× 60 0.2× 130 0.5× 13 833
Christine L. O’Keefe United States 24 447 0.7× 1.2k 2.3× 78 0.2× 134 0.4× 457 1.6× 54 2.9k
Naoki Kitabayashi United States 17 138 0.2× 844 1.6× 61 0.1× 156 0.4× 172 0.6× 19 1.5k

Countries citing papers authored by Y Möroi

Since Specialization
Citations

This map shows the geographic impact of Y Möroi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Möroi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Möroi more than expected).

Fields of papers citing papers by Y Möroi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Möroi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Möroi. The network helps show where Y Möroi may publish in the future.

Co-authorship network of co-authors of Y Möroi

This figure shows the co-authorship network connecting the top 25 collaborators of Y Möroi. A scholar is included among the top collaborators of Y Möroi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Möroi. Y Möroi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Hashimoto, Akira, Hajime Satō, Yoshihiro Ishihara, et al.. (2001). [A multicenter cross-sectional study on the Health Related Quality of Life of patients with rheumatoid arthritis using a revised Japanese version of the Arthritis Impact Measurement Scales Version 2 (AIMS 2), focusing on physical disability and its associative factors].. PubMed. 41(1). 23–24. 7 indexed citations
3.
Satō, Hajime, S Araki, Atsushi Hashimoto, et al.. (1995). [Quality of life, subjective health status and health and life satisfaction in rheumatoid arthritis].. PubMed. 42(9). 743–54. 3 indexed citations
4.
Takeuchi, F, Ken Nakano, Haruki Yamada, et al.. (1992). Chromosome abnormalities in peripheral lymphocytes from patients with progressive systemic sclerosis. Rheumatology International. 12(6). 243–246. 1 indexed citations
5.
Shu, U., F Takeuchi, Kiyoaki Tanimoto, et al.. (1992). Transient myopia with severe chemosis associated with exacerbation of disease activity in systemic lupus erythematosus.. PubMed. 19(2). 297–301. 12 indexed citations
6.
Möroi, Y, et al.. (1990). Cerebral hemiatrophy in systemic lupus erythematosus: Report of a case.. Japanese Journal of Medicine. 29(4). 423–428. 2 indexed citations
7.
Miura, Hitoshi, Y Möroi, S Yoshinoya, et al.. (1988). Isolation and characterization of a complementary DNA expressing human U1 small nuclear ribonucleoprotein C polypeptide.. The Journal of Immunology. 140(1). 311–317. 51 indexed citations
8.
Tsuchiya, Naoyuki, Minako Goto, Y Möroi, et al.. (1988). 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.. PubMed. 15(6). 946–51. 11 indexed citations
9.
Takizawa, Hitoshi, et al.. (1987). Interstitial lung disease in dermatomyositis: clinicopathological study.. PubMed. 14(1). 102–7. 91 indexed citations
10.
Takehara, Kazuhiko, Y Möroi, & Y. Ishibashi. (1985). Antinuclear antibodies in the relatives of patients with systemic sclerosis. British Journal of Dermatology. 112(1). 23–33. 39 indexed citations
11.
Wagatsuma, Masako, Masuo Obinata, Y Möroi, Fumio Hanaoka, & Masa-atsu Yamada. (1985). Detection of β-Globin mRNA Precursor in Heterogeneous Nuclear Ribonucleoprotein Associated with Ul-RNP by Using Anti-RNP Antibody1. The Journal of Biochemistry. 97(6). 1727–1735. 3 indexed citations
12.
Nakano, Ken, et al.. (1985). Detection of antinuclear ribonucleoprotein (nRNP) antibody producing cells in peripheral blood lymphocytes from patients with mixed connective tissue disease.. PubMed. 12(5). 924–7. 1 indexed citations
13.
Ishibashi, Y., et al.. (1984). [Immunologic abnormalities in localized scleroderma].. PubMed. 94(2). 121–8. 1 indexed citations
14.
Takehara, Kazuhiko, et al.. (1983). Antinuclear Antibodies in Localized Scleroderma. Arthritis & Rheumatism. 26(5). 612–616. 107 indexed citations
15.
Möroi, Y, Ichiro Murata, Akiteru Takeuchi, et al.. (1983). Human anticentriole autoantibody in patients with scleroderma and Raynaud's phenomenon. Clinical Immunology and Immunopathology. 29(3). 381–390. 34 indexed citations
16.
Möroi, Y, et al.. (1981). Distribution of kinetochore (centromere) antigen in mammalian cell nuclei.. The Journal of Cell Biology. 90(1). 254–259. 128 indexed citations
17.
Tan, Eng M., Gerald P. Rodnan, Ignacio Garcı́a-De La Torre, et al.. (1980). Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis & Rheumatism. 23(6). 617–625. 421 indexed citations breakdown →
18.
Möroi, Y, Carol Peebles, Marvin J. Fritzler, James C. Steigerwald, & Eng M. Tan. (1980). Autoantibody to centromere (kinetochore) in scleroderma sera.. Proceedings of the National Academy of Sciences. 77(3). 1627–1631. 581 indexed citations breakdown →
19.
Kanai, Yoshiyuki, Masanao Miwa, Taijiro Matsushima, et al.. (1977). Naturally-occurring antibodies to poly(ADP-ribose) in patients with systemic lupus erythematosus. Nature. 265(5590). 175–177. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026